Trex Medical
This article was originally published in The Gray Sheet
Executive Summary
Trex Medical: Mammography/x-ray manufacturer grosses $71.2 mil. in a secondary offering of 5.2 mil. shares of common stock at $13.75 per share, including all 675,000 overallotment shares. Proceeds will be used to finance the firm's acquisition of dental x-ray system maker Trophy Radiologie ("The Gray Sheet" Jan. 12, In Brief). Underwriters for the offering include Salomon Smith Barney, Lehman Brothers and Prudential Securities...
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.